CME Outfitters: Continuing Medical Education With Integrity

Education
With Integrity

  Site Coordinators OnlyFaculty OnlyReps Only  

CME Outfitters Home
About Us
CMEO in the News
Joint Sponsorship
Register Your Institution
Register to Participate
CME/CE Activities
Self-Study Materials
Resources
Contact Information
Careers at CMEO
Search

 

 


ACTIVITY DETAILS

New PCI Guidelines: An Interactive Debate with Experts on Indications and Implementations

CMEO Webcast

Premiere Date: Sunday, March 30, 2008

This activity offers CE credit for:

  1. Physicians (ACCME/AMA PRA Category 1)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Monday, March 30, 2009

Faculty


ChristopherP. Cannon, MDMODERATOR:
Christopher P. Cannon, MD
Senior Investigator, TIMI Study Group
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

DavidR. Holmes, Jr., MDDavid R. Holmes, Jr., MD
Professor of Medicine
Mayo Clinic
Rochester, MN

EricR. Bates, MDEric R. Bates, MD
Professor, Department of Internal Medicine
University of Michigan
Detroit, MI

Statement of Need

The 2007 Percutaneous Coronary Intervention (PCI) "Focused Update" to the American College of Cardiology (ACC)/American Heart Association (AHA)/Society for Cardiovascular Angiography and Interventions (SCAI) practice guidelines(1) was recently published to keep interventionalists up to date on the stream of new data available. New studies have been incorporated to guide the indications for an invasive strategy in patients with acute coronary syndrome (ACS), including those with ST elevation myocardial infarction (STEMI) and unstable angina/non-STEMI. In addition, many studies have shown that improving inhibition of platelet aggregation is key to improving outcomes in these patients.(2) Controversy remains, however, as to the precise dosing, combination and timing of antiplatelet therapies in ACS patients being managed with PCI. Adherence to the ACC/AHA/SCAI guidelines is not universal, and hospitals and practitioners vary in how the guidelines are implemented. Newer therapies and improved understanding of how to use existing therapies are important for improving patient outcomes.

The faculty panel will review and discuss the "focused update" for the management of ACS in PCI-treated patients, and will report on recent findings related to emerging agents and dosing regimens.


  1. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. JACC 2008;51:1-38.
  2. Davies MJ. Pathology of arterial thrombosis. Br Med Bull 1994;50:789-802.
This event is not part of the official ACC Annual Scientific Session and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit as planned by their Program Committees.

Activity Goal

To provide an overview of current and emerging treatment strategies for patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Describe the benefits of incorporating practice guidelines in ACS patients undergoing PCI treatment.
  • Identify important evidence-based findings regarding the timing of PCI treatment in ACS patients.
  • Evaluate emerging research related to new therapies for the management of ACS patients undergoing PCI.

Target Audience

Interventional cardiologists, physician assistants, nurses, nurse practitioners, pharmacists, and other clinicians who treat patients with acute coronary syndrome.

Commercial Support

CME Outfitters, LLC, gratefully acknowledges an educational grant from Schering-Plough Corporation in support of this CE activity.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned code 6WASUP-PRV-0631. 1.5 contact hours will be awarded upon successful completion.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)
Universal Program Number: 376-000-08-007-L01-P (live presentation) 376-000-08-007-H01-P (recorded programs)

Post-tests, credit request forms, and activity evaluations can be completed online at www.CMEoutfitters.com/test (requires free account activation), and participants can print their certificate and statement of credit immediately (70% pass rate required).

Questions about this CE activity? Call us at 877.CME.PROS (877.263.7767).

MM-015-033008-18

© 2002-2008 CME Outfitters, LLC
Contact Information :: Privacy :: Legal
Powered by CME Outfitters

continuing medical education

psych

cme

psychiatry cme

online cme

mghcme

neuroscience cme

psychlink

i3dln

mgh-pa